Michael Pardi, et al. v. Tricida, Inc., et al.

CourtDistrict Court, N.D. California
DecidedOctober 23, 2025
Docket4:21-cv-00076
StatusUnknown

This text of Michael Pardi, et al. v. Tricida, Inc., et al. (Michael Pardi, et al. v. Tricida, Inc., et al.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Michael Pardi, et al. v. Tricida, Inc., et al., (N.D. Cal. 2025).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 MICHAEL PARDI, et al., Case No. 21-cv-00076-HSG

8 Plaintiffs, ORDER GRANTING MOTION FOR FINAL APPROVAL, MOTION FOR 9 v. ATTORNEYS’ FEES AND COSTS, AND LEAD PLAINTIFF’S MOTION FOR 10 TRICIDA, INC., et al., AWARD OF REASONABLE COSTS AND EXPENSES 11 Defendants. Re: Dkt. Nos. 223, 224, 225 12 13 Pending before the Court are Lead Plaintiff’s unopposed motions for final approval of 14 class action settlement, for attorneys’ fees and costs, and for award of reasonable costs. Dkt. Nos. 15 223, 224, 225. The Court held a final fairness hearing on October 16, 2025. For the reasons 16 detailed below, the Court GRANTS the motions. 17 I. BACKGROUND 18 A. Factual Allegations 19 Tricida, Inc. was a clinical-stage biopharmaceutical company.1 See Dkt. No. 142 (“Second 20 Amended Complaint” or “SAC”) at ¶ 45. Its lead investigational drug candidate, veverimer, was 21 intended to slow the progression of chronic kidney disease. Id. at ¶¶ 4, 45, 62. Tricida submitted 22 veverimer to the U.S. Food and Drug Administration (“FDA”) for approval and the FDA accepted 23 Tricida’s New Drug Application (“NDA”) for review. Id. at ¶ 71. Lead Plaintiff alleges that the 24 FDA identified “significant issues” with the NDA based on veverimer’s trial data. Id. at ¶¶ 20, 25 22–23, 25, 72–77. Notwithstanding these concerns, however, Lead Plaintiff alleges that 26 Defendants misled investors regarding the likelihood that the FDA would approve the NDA. See, 27 1 e.g., id. at ¶¶ 4, 26, 41. The FDA ultimately denied the NDA and Tricida’s subsequent appeal. 2 See id. ¶¶ 30, 32, 86, 90–92, 182. Lead Plaintiff alleges that Tricida’s stock price repeatedly fell 3 following Tricida’s announcement of this news. See id. at ¶¶ 28–29, 31–33, 79, 88, 93, 175, 178, 4 181, 184, 186. 5 B. Procedural Background 6 On January 6, 2021, Plaintiff Michael Pardi filed an initial complaint against both Tricida 7 and Defendant Gerritt Klaerner, alleging violations of Sections 10(b) and 20(a) of the Securities 8 Exchange Act and Rule 10b-5. See Dkt. No. 1. In April 2021, the Court appointed Jeffrey M. 9 Fiore as Lead Plaintiff and Block & Leviton LLP as Lead Counsel.2 Dkt. No. 65. On January 11, 10 2023, Tricida filed a voluntary petition for reorganization under Chapter 11 of the bankruptcy 11 code in the United States Bankruptcy Court for the District of Delaware, and Lead Plaintiff 12 subsequently moved to voluntarily dismiss Tricida from this case without prejudice.3 See Dkt. 13 Nos. 120, 125. The Court granted the motion and Defendant Klaerner, therefore, is the only 14 remaining Defendant in this case. See Dkt. 132. 15 The parties engaged in significant motions practice, including several rounds of motions to 16 dismiss. See, e.g., Dkt. Nos. 76, 128. In September 2024, the Court granted Lead Plaintiff’s 17 Motion to Certify Class, Appoint Class Representative, and Appoint Class Counsel. See Dkt. No. 18 188. The Court (1) certified a class of investors who acquired Tricida common stock from May 8, 19 2020, to February 25, 2021 (the “Class Period”), (2) appointed Lead Plaintiff as class 20 representative, and (3) appointed Block & Leviton LLP as class counsel. Id. The parties then 21 engaged in substantial discovery. See Dkt. No. 211 at 6–8; see also Dkt. No. 211-1 (“Block 22 Decl.”) at ¶¶ 3–17. The Court granted preliminary approval of the proposed class action 23 settlement in May 2025. Dkt. No. 220. 24 // 25

26 2 This case was originally assigned to Judge Lucy H. Koh and reassigned to the undersigned in January 2022. See Dkt. No. 90. 27 3 In May 2023, the Bankruptcy Court approved Tricida’s chapter 11 plan of liquidation, and the 1 C. Settlement Agreement 2 In April and November 2024, the parties participated in mediation with Michelle Yoshida 3 of Phillips ADR. See Block Decl. at ¶¶ 19–22. The parties ultimately entered into a settlement 4 agreement, fully executed in March 2025. See Dkt. No. 211-2 (“Settlement Agreement” or “SA”). 5 The key terms are as follows: 6 Class Definition: The Class is defined the same as in the Court’s prior order granting class 7 certification as “all persons or entities who purchased or otherwise acquired common stock of 8 Tricida, Inc. during the period from May 8, 2020 to February 25, 2021.” Id. at §§ 1.3, 1.5. The 9 Class definition excludes anyone who validly seeks exclusion from the Class or whose request for 10 exclusion the Court accepts. Id. at § 1.3. 11 Settlement Benefits: Defendant Klaerner will make a non-reversionary payment of 12 $14,250,000. See id. at §§ 1.27, 3.1, 3.3, 6.8. The Settlement Fund also includes taxes and tax 13 expenses, Court-approved attorneys’ fees and costs, settlement administration fees, any additional 14 award to Lead Plaintiff, and payments to Class Members. See id. at §§ 1.17, 3.9, 6.3, 7.1–7.2. 15 The cash payments to the Class will be based on a “Plan of Allocation,” which was included as 16 part of the notice to Class Members. See id. at §§ 1.22, 6.4–6.7; see also Dkt. No. 223-2, Ex. 1 17 (“Cormio Decl.”). 18 The Plan of Allocation provides a formula for determining the “Recognized Loss Amount” 19 for transactions during the Class Period. See id., Ex. A at 16–10. It accounts for factors including 20 when the common stock was purchased or otherwise acquired during the Class Period; the amount 21 of stock acquired; whether such stock was sold, and if so, the timing and proceeds of the sales; and 22 the “artificial inflation” of the stock during that time. See id. 23 Each Class Member was required to submit a Proof of Claim and Release form to the 24 Claims Administrator by October 1, 2025, to be eligible for a payment from the Settlement Fund. 25 See SA at § 6.5; see also Cormio Decl., Ex. A at 25–32. The parties have estimated that Class 26 Members will receive approximately $.40 per share of Tricida common stock and Authorized 27 Claimants with any Recognized Loss Amount greater than zero will receive a minimum of $10.00. 1 Claims Administrator’s current assessments, the average recovery will be approximately $2,000 2 per Claimant, although the top 200 Claimants thus far represent approximately 90% of the total 3 Recognized Loss. 4 Cy Pres Distribution: If there is any balance remaining in the Net Settlement Fund after a 5 reasonable period of time after the initial distribution of funds, the Claims Administrator shall, if 6 feasible, redistribute the balance among Authorized Claimants until the remaining balance is de 7 minimis. See SA at § 6.8. Any de minimis balance will be donated to the Bluhm Legal Clinic 8 Center for Litigation and Investor Protection at Northwestern University Pritzker School of Law. 9 Id. 10 Release: All Class Members will release Defendant, “Former Defendant” Tricida, Inc., 11 and their family members and related parties from:

12 any and all claims and causes of action of every nature and description 13 whatsoever as against the Released Defendant Parties that have been or could have been asserted in this or any other action that arise out 14 of, are based upon, or relate in any way to both: (a) any of the allegations, acts, transactions, facts, events, matters, occurrences, 15 representations or omissions involved, set forth, alleged or referred to in this action, or which could have been alleged in this action, and (b) 16 the purchase, acquisition, holding, sale, or disposition of Tricida securities by any Class Member during the Class Period, including 17 Unknown Claims as defined in ¶ 1.31 hereof, whether arising under federal, state, local, common, statutory, administrative, or foreign 18 law, or any other law, rule, or regulation, at law or in equity, whether fixed or contingent, whether foreseen or unforeseen, whether accrued 19 or unaccrued, whether liquidated or unliquidated, whether matured or unmatured, whether direct, representative, class, or individual in 20 nature.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Charles
213 F.3d 10 (First Circuit, 2000)
Silber v. Mabon
18 F.3d 1449 (Ninth Circuit, 1994)
In Re Washington Public Power Supply System Securities Litigation. Class Chemical Bank, in Its Representative Capacity as Trustee for Bondholders, and Bernstein, Litowitz, Berger & Grossman Milberg, Weiss, Bershad, Specthrie & Lerach Molloy, Jones & Donahue, P.C. v. City of Seattle Oregon Public Entities, Benton Rural Electric Association, Washington Washington Public Power Supply System R.W. Beck and Associates Ebasco Services Incorporated United Engineers & Constructors, Inc. Director Participants' Committee Public Utility District No. 1, of Klickitat County United States of America, on Behalf of Itself and Its Agency, the Bonneville Power Administration State of Washington Bonneville Power Administration, Class and Lawrence Laub v. Continental Assurance Company v. City of Seattle Oregon Public Entities, Benton Rural Electric Association, Washington Washington Public Power Supply System R.W. Beck and Associates Ebasco Services Incorporated United Engineers & Constructors, Inc. Director Participants' Committee Public Utility District No. 1, of Klickitat County United States of America, on Behalf of Itself and Its Agency, the Bonneville Power Administration State of Washington Bonneville Power Administration, Class and Continental Assurance Company v. Berger & Montague, P.A. v. City of Seattle Oregon Public Entities, Benton Rural Electric Association, Washington Washington Public Power Supply System R.W. Beck and Associates Ebasco Services Incorporated United Engineers & Constructors, Inc. Director Participants' Committee Public Utility District No. 1, of Klickitat County United States of America, on Behalf of Itself and Its Agency, the Bonneville Power Administration State of Washington Bonneville Power Administration
19 F.3d 1291 (Ninth Circuit, 1994)
Staton v. Boeing Co.
327 F.3d 938 (Ninth Circuit, 2003)
Harry Dennis v. Stephanie Berg
697 F.3d 858 (Ninth Circuit, 2012)
Rodriguez v. West Publishing Corp.
563 F.3d 948 (Ninth Circuit, 2009)
Chun-Hoon v. McKee Foods Corp.
716 F. Supp. 2d 848 (N.D. California, 2010)
Robert Briseno v. Conagra Foods, Inc.
998 F.3d 1014 (Ninth Circuit, 2021)
Elmore v. Cone Mills Corp.
6 F.3d 1028 (Fourth Circuit, 1993)
Harris v. Marhoefer
24 F.3d 16 (Ninth Circuit, 1994)
Hanlon v. Chrysler Corp.
150 F.3d 1011 (Ninth Circuit, 1998)
Vizcaino v. Microsoft Corp.
290 F.3d 1043 (Ninth Circuit, 2002)
In re Linkedin User Privacy Litigation
309 F.R.D. 573 (N.D. California, 2015)
David Lowery v. Rhapsody International, Inc.
75 F.4th 985 (Ninth Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Michael Pardi, et al. v. Tricida, Inc., et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/michael-pardi-et-al-v-tricida-inc-et-al-cand-2025.